Amgen Gets CHMP's Positive Opinion To Extend Indication Of Kyprolis For Relapsed Multiple Myeloma Treatment
May 27, 2016 at 12:09 PM EDT
Amgen (NASDAQ: AMGN) revealed that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has ...